| Product Code: ETC9925350 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Medical Condition, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about irritable bowel syndrome (IBS) in the UAE |
4.2.2 Growing prevalence of IBS among the population |
4.2.3 Rising demand for effective IBS treatment options in the UAE |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals for IBS management |
4.3.2 High cost associated with IBS treatment options in the UAE |
4.3.3 Cultural stigma and lack of open discussion about digestive health issues |
5 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Trends |
6 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market, By Types |
6.1 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Lubiprostone, 2021- 2031F |
6.1.4 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Linaclotide, 2021- 2031F |
6.1.5 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Eluxadoline, 2021- 2031F |
6.1.6 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Rifaximin, 2021- 2031F |
6.1.7 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Alosetron, 2021- 2031F |
6.1.8 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market, By Medical Condition |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-Constipation, 2021- 2031F |
6.2.3 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-diarrhea, 2021- 2031F |
6.2.4 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Mixed, 2021- 2031F |
6.3 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.4 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
7 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Imports from Major Countries |
8 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Key Performance Indicators |
8.1 Number of IBS awareness campaigns conducted annually |
8.2 Percentage increase in IBS diagnosis rates in the UAE |
8.3 Patient satisfaction scores related to IBS treatment options in the UAE |
9 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Medical Condition, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Irritable Bowel Syndrome (IBS) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here